FDA-BCAN Workshop: Endpoints for the Development of Neoadjuvant Systemic Therapy Regimens for Muscle-Invasive Bladder Cancer (MIBC)
- Calendar
- Urology - General
- Date
- Aug 08, 2019 12:00 pm - 4:00 pm
Description
This workshop brings together stakeholders in the care of patients with muscle-invasive bladder cancer including clinicians, regulatory scientists, biostatisticians, patients, advocates, and industry representatives. Its goals are to define the current state of knowledge regarding endpoints to accelerate the development of systemic therapy regimens in the neoadjuvant setting, identify knowledge gaps, plan strategies for evidence development and generate regulatory guidance to inform ongoing/future clinical trials.
Location: Capital Hilton, Washington, DC, United States
2019 Program
Location: Capital Hilton, Washington, DC, United States
2019 Program